These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7058911)

  • 21. Chlorthalidone alters the vascular reactivity of DOC-salt hypertensive rats to norepinephrine.
    Musso MN; Vasquez EC; Carvalhinho FB; Bissoli NS; Cabral AM
    Braz J Med Biol Res; 1990; 23(10):999-1003. PubMed ID: 2101067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of an intracerebroventricularly administered vasopressin V1 antagonist on blood pressure and heart rate in deoxycorticosterone-salt hypertensive rats.
    Toba K; Ouchi Y; Liang J; Akishita M; Orimo H
    J Auton Nerv Syst; 1994 Dec; 50(2):123-9. PubMed ID: 7884152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.
    Supowit SC; Zhao H; Hallman DM; DiPette DJ
    Hypertension; 1997 Apr; 29(4):945-50. PubMed ID: 9095081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats.
    McAreavey D; Brown WB; Murray GD; Robertson JI
    J Hypertens; 1985 Jun; 3(3):275-9. PubMed ID: 3894516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of vasopressin in hypertension.
    Share L; Crofton JT
    Fed Proc; 1984 Jan; 43(1):103-6. PubMed ID: 6690329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats.
    Bruner CA; Mangiapane ML; Fink GD; Webb RC
    Hypertension; 1988 Jun; 11(6 Pt 2):668-73. PubMed ID: 3391678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
    Möhring J; Möhring B; Petri M; Haack D
    Am J Physiol; 1977 Mar; 232(3):F260-9. PubMed ID: 842673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of DOCA-salt hypertension in the Brattleboro rat.
    Saito T; Yajima Y
    Ann N Y Acad Sci; 1982; 394():309-18. PubMed ID: 6960765
    [No Abstract]   [Full Text] [Related]  

  • 32. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of AVP and deoxycorticosterone on Na+ and water transport in the Dahl salt-sensitive rat CCD.
    Hawk CT; Schafer JA
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F471-8. PubMed ID: 1849360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exchangeable sodium measured serially in DOC-salt, post-DOC-salt, and Goldblatt hypertension in the rat.
    McAreavey D; Brown WB; Robertson JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S126-33. PubMed ID: 6204131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine.
    Takeshita A; Mark AL; Brody MJ
    Am J Physiol; 1979 Jan; 236(1):H48-52. PubMed ID: 434173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular hemodynamics and vasopressin blockade in DOCA-salt hypertensive rats.
    Yamamoto J; Yamane Y; Umeda Y; Yoshioka T; Nakai M; Ikeda M
    Hypertension; 1984; 6(3):397-407. PubMed ID: 6735459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary chloride and bicarbonate as determinants of desoxycorticosterone hypertension.
    Kurtz TW; Morris RC
    J Hypertens Suppl; 1984 Dec; 2(3):S371-3. PubMed ID: 6100744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic and regional hemodynamic effects of dietary calcium supplementation in mineralocorticoid hypertension.
    DiPette DJ; Greilich PE; Kerr NE; Graham GA; Holland OB
    Hypertension; 1989 Jan; 13(1):77-82. PubMed ID: 2910816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.